Researchers at UT Southwestern Medical Center have found that alternative splicing — a process that allows a single gene to code for multiple proteins — appears to be a new potential target for anti-telomerase cancer therapy.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/usm…